Australia · Delayed Price · Currency is AUD Skinkandy Statistics
Total Valuation
Skinkandy has a market cap or net worth of AUD 312.67 million. The enterprise value is 326.69 million.
| Market Cap | 312.67M |
| Enterprise Value | 326.69M |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Skinkandy has 111.67 million shares outstanding. The number of shares has decreased by -1.17% in one year.
| Current Share Class | 111.67M |
| Shares Outstanding | 111.67M |
| Shares Change (YoY) | -1.17% |
| Shares Change (QoQ) | +4.24% |
| Owned by Insiders (%) | 11.76% |
| Owned by Institutions (%) | 57.47% |
| Float | 82.75M |
Valuation Ratios
The trailing PE ratio is 487.78 and the forward PE ratio is 26.03. Skinkandy's PEG ratio is 0.84.
| PE Ratio | 487.78 |
| Forward PE | 26.03 |
| PS Ratio | 3.45 |
| PB Ratio | 7.02 |
| P/TBV Ratio | 8.75 |
| P/FCF Ratio | 521.98 |
| P/OCF Ratio | 38.91 |
| PEG Ratio | 0.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.18, with an EV/FCF ratio of 545.39.
| EV / Earnings | 509.65 |
| EV / Sales | 3.61 |
| EV / EBITDA | 13.18 |
| EV / EBIT | 22.46 |
| EV / FCF | 545.39 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.28 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 1.12 |
| Debt / FCF | 46.47 |
| Interest Coverage | 11.55 |
Financial Efficiency
Return on equity (ROE) is 1.71% and return on invested capital (ROIC) is 8.57%.
| Return on Equity (ROE) | 1.71% |
| Return on Assets (ROA) | 12.69% |
| Return on Invested Capital (ROIC) | 8.57% |
| Return on Capital Employed (ROCE) | 22.52% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.85M |
| Profits Per Employee | 13,082 |
| Employee Count | 49 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 1.57 |
Taxes
In the past 12 months, Skinkandy has paid 1.22 million in taxes.
| Income Tax | 1.22M |
| Effective Tax Rate | 65.50% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.66 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 60.11 |
| Average Volume (20 Days) | 128,862 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Skinkandy had revenue of AUD 90.51 million and earned 641,000 in profits. Earnings per share was 0.01.
| Revenue | 90.51M |
| Gross Profit | 80.74M |
| Operating Income | 14.55M |
| Pretax Income | 1.86M |
| Net Income | 641,000 |
| EBITDA | 17.86M |
| EBIT | 14.55M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 13.82 million in cash and 27.84 million in debt, with a net cash position of -14.02 million or -0.13 per share.
| Cash & Cash Equivalents | 13.82M |
| Total Debt | 27.84M |
| Net Cash | -14.02M |
| Net Cash Per Share | -0.13 |
| Equity (Book Value) | 44.54M |
| Book Value Per Share | 0.40 |
| Working Capital | 4.72M |
Cash Flow
In the last 12 months, operating cash flow was 8.04 million and capital expenditures -7.44 million, giving a free cash flow of 599,000.
| Operating Cash Flow | 8.04M |
| Capital Expenditures | -7.44M |
| Depreciation & Amortization | 3.32M |
| Net Borrowing | -7.80M |
| Free Cash Flow | 599,000 |
| FCF Per Share | 0.01 |
Margins
Gross margin is 89.20%, with operating and profit margins of 16.07% and 0.71%.
| Gross Margin | 89.20% |
| Operating Margin | 16.07% |
| Pretax Margin | 2.05% |
| Profit Margin | 0.71% |
| EBITDA Margin | 19.73% |
| EBIT Margin | 16.07% |
| FCF Margin | 0.66% |
Dividends & Yields
Skinkandy does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1,326.05% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.17% |
| Shareholder Yield | 1.17% |
| Earnings Yield | 0.21% |
| FCF Yield | 0.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Skinkandy is 2.97, which is 6.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2.97 |
| Price Target Difference | 6.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 18.24% |
| EPS Growth Forecast (3Y) | 22.58% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Skinkandy has an Altman Z-Score of 6.1 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.1 |
| Piotroski F-Score | 5 |